98%
921
2 minutes
20
Sleep and circadian disruption (SCD) is common and severe in the ICU. On the basis of rigorous evidence in non-ICU populations and emerging evidence in ICU populations, SCD is likely to have a profound negative impact on patient outcomes. Thus, it is urgent that we establish research priorities to advance understanding of ICU SCD. We convened a multidisciplinary group with relevant expertise to participate in an American Thoracic Society Workshop. Workshop objectives included identifying ICU SCD subtopics of interest, key knowledge gaps, and research priorities. Members attended remote sessions from March to November 2021. Recorded presentations were prepared and viewed by members before Workshop sessions. Workshop discussion focused on key gaps and related research priorities. The priorities listed herein were selected on the basis of rank as established by a series of anonymous surveys. We identified the following research priorities: establish an ICU SCD definition, further develop rigorous and feasible ICU SCD measures, test associations between ICU SCD domains and outcomes, promote the inclusion of mechanistic and patient-centered outcomes within large clinical studies, leverage implementation science strategies to maximize intervention fidelity and sustainability, and collaborate among investigators to harmonize methods and promote multisite investigation. ICU SCD is a complex and compelling potential target for improving ICU outcomes. Given the influence on all other research priorities, further development of rigorous, feasible ICU SCD measurement is a key next step in advancing the field.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10111990 | PMC |
http://dx.doi.org/10.1164/rccm.202301-0184ST | DOI Listing |
Saudi J Med Med Sci
July 2025
College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
Background: The use of morphine in managing vaso-occlusive crisis (VOC) in patients with sickle cell disease (SCD) can result in significant side effects. Nalbuphine, a mixed agonist-antagonist opioid, may offer an alternative with fewer complications.
Objective: To compare the efficacy and safety of nalbuphine and morphine in pain management among adult SCD patients presenting with VOC.
Introduction: Despite recent advances in sickle cell disease (SCD) research and management, there remains very limited information available on critically ill SCD patients requiring intensive care units (ICUs).
Methods: The National Inpatient Sample was queried using the International Classification of Diseases codes to identify critically ill patients with SCD requiring ICU admission. These patients were further stratified into those with and without adverse clinical events (ACEs).
Thromb J
July 2025
Department of Surgery, American University of Beirut Medical Center, Bliss Street, PO Box 11-0236, Beirut, Lebanon.
Objective: The link between venous thromboembolism (VTE) and coronavirus disease 2019 (COVID-19) infection has been consolidated by many studies in the literature. The increased risk of VTE among COVID-19 patients, on the one hand, and the morbidity that can be associated with the ICU course, on the other hand, promote quality care among this patient population. "Choosing wisely" is a quality improvement initiative that emphasizes the importance of assessing the utility of diagnostic tests.
View Article and Find Full Text PDFAm Surg
September 2025
Department of Trauma, Ballad Health Trauma Services, Johnson City, TN, USA.
Venous thromboembolism (VTE) risk is significantly higher for hospitalized trauma patients. Sequential compression devices (SCDs) serve as standard mechanical prophylaxis for VTE; however, compliance remains suboptimal. We examined frequency of SCD usage and barriers to utilization.
View Article and Find Full Text PDFBlood Adv
June 2025
CHU Henri-Mondor, APHP, Créteil, France.
Parvovirus B19 infection can lead to severe complications in patients with chronic haemolysis. The aim of this study was to describe severe Parvovirus B19 infections in adult patients with sickle cell disease (SCD). In this multicentre, retrospective, observational cohort study, adult patients with SCD admitted to intensive care units (ICUs) between 2011 and 2024 with acute Parvovirus B19 infection were included.
View Article and Find Full Text PDF